β-haemolytic streptococci in acute pharyngitis

Eastern Mediterranean Health Journal

Volumn 9, Issue 1-2, 2003, Pages 172-177

  Boukadida, Jalel ^a   Hannechi, N ^a   Boukadida, N ^b   Ben Said, H ^b   Elmherbech, H ^a   Errai, S ^a  

^a FARHAT HACHED HOSPITAL   (Tunisia)

^b Primary Health Care Service   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CHLORAMPHENICOL; ERYTHROMYCIN; FOSFOMYCIN; LEVOFLOXACIN; PENICILLIN G; PRISTINAMYCIN; RIFAMPICIN; TELITHROMYCIN; TETRACYCLINE; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ALERTNESS; ANALYTIC METHOD; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BETA HEMOLYTIC STREPTOCOCCUS; CHILD; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHARYNGITIS; PRIMARY HEALTH CARE; STREPTOCOCCUS GROUP A; STREPTOCOCCUS GROUP C; STREPTOCOCCUS GROUP G; THROAT CULTURE; TUNISIA; ACUTE DISEASE; AGE DISTRIBUTION; ANTIBIOTIC RESISTANCE; HEALTH SURVEY; INCIDENCE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; PATIENT SELECTION; PRESCHOOL CHILD; PREVALENCE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES;

ACUTE DISEASE; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; HUMANS; INCIDENCE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PATIENT SELECTION; PHARYNGITIS; POPULATION SURVEILLANCE; PREVALENCE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; TUNISIA;

EID: 16544374018     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Bisno AL. Acute pharyngitis. New England journal of medicine, 2001, 344: 205-11.
2. Cooper RJ et al. Principles of appropriate antibiotic use for acute pharyngitis in adults: Background. Annals of internal medicine 2001, 134:509-17.
3. Bertrand E, Gerard R. Prévalence hospitalière des cardiopathies rhumatismales et du rhumatisme articulaire aigu comparée en France et en Afrique. [Comparison of hospital prevalence of rheumatic heart diseases and acute rheumatic arthritis in France and Africa]. Archive des maladies du cœur et des vaisseaux, 1993, 86:291-5. Erratum in: Archive des maladies du cœur et des vaisseaux, 1993, 86:920.
4. Nandi S et al. Group A streptococcal sore throat in a periurban population of northern India: a one-year prospective study. Bulletin of the World Health Organization, 2001, 79:28-33.
5. Besno AL et al. Diagnosis and management of Group A streptococcal pharyngitis: a practice guideline. Infectious Diseases Society of America. Clinical infectious diseases, 1997, 25:574-83.
6. Performance standards for antimicrobial susceptibility testing: Ninth informational supplement. National Committee for Clinical Laboratory Standards document M100-S9. Vol. 19:1. Villanova, Pennsylvania, NCCLS, 1999:90-1.
7. Bassetti M et al. Erythromycin resistance in Streptococcus pyogenes in Italy. Emerging infootious diseases, 2000, 6: 186-3.
8. Cohen R et al. Epidémiologie bactérienne des angines en pratique pédiatrique de ville. [Bacterial epidemiology of pharyngitis in paediatric private practice]. Presse médicale, 1994, 23: 1753-7.
9. Webb KH. Does culture confirmation of high-sensitivity rapid streptococcal tests make sense? A medical decision analysis. Pediatrics, 1998, 101:E2.
10. Descheemaeker P et al. Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates. Journal of antimicrobial chemotherapy, 2000, 45:167-73.
11. Karasawa T, Takahashi K, Nakamura S. Epidemiological survey of betahemolytic streptococci isolated from acute pharyngitis in a private pediatric practice. Japanese journal infectious diseases, 2001, 54:76-7.
12. Portillo A et al. MLS resistance phenotypes and mechanisms in betahaemolytic group B, C and G Streptococcus isolates in La Rioja, Spain. Journal of antimicrobial chemotherapy, 2001, 47:115-6.
13. Carbon C, Bax PR. Regulating the use of antibiotics in the community. Britsh medical journal, 1998, 317:663-5.
14. Bingen E et al. Resistance to macrolides in Streptococcus pyogenes in France in pediatric patients. Antimicrobial agents and chemotherapy, 2000, 44:1453-7.
15. Jalava J et al. In vitro activities of the novel ketolide telithromycin (HMR 3647) against erythromycin-resistant Streptococcus species. Antimicrobial agents and chemotherapy, 2001, 45:789-93.
16. Nagai K et al. Susceptibility to telithromycin in 1011 Streptococcus pyogenes isolates from 10 central and Eastern European countries. Antimicrobial agents and chemotherapy, 2002, 46: 459-546.
17. Granizo JJ et al. Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997). Journal of antimicrobial chemotherapy, 2000, 46:959-64.
18. Gonzalez-Lama Z et al. Sensibilidad a antibióticos en estreptococos beta hemolíticos de los grupos A, B y C. [Sensitivity of groups A, B and C beta hemolytic streptococci to antibiotics]. Revista Espanola quimioterapia, 1999, 12:215-9.
19. Turner JC et al. Role of group C betahemolytic streptococci in pharyngitis: epidemiologic study of clinical features associated with isolation of group C streptococci. Journal of clinical microbiology 1993, 31:808-11.
20. Weeber P et al. Genetic and phenotypic characterization of macrolide resistance in group A streptococci isolated from adults with pharyngo-tonsillitis in France. Journal of antimicrobial chemotherapy 2001, 48:291-4.